Products for Research Use Only
RegisterLogin

Navicixizumab

CAT: 0931-T76871Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T76871Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1638338-43-8
Target
Gamma-secretase
Related Pathways
Stem Cells, Neuroscience, Proteases/Proteasome
Bioactivity
Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody that can be combined with Paclitaxel for cancer research, particularly in studies of ovarian, primary peritoneal, or fallopian tube cancer [1] [2] [3].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
MBS5818796Navicixizumab
GTR18337906-01Navicixizumab Antibody
KPTX278Navicixizumab ELISA Kit
E55B1237Navicixizumab (Reference antibody)
A2519-1mgNavicixizumab (Anti-DLL4)
HV571036-01Research Grade Navicixizumab
KBI1492KRIBIOLISA™ Navicixizumab ELISA
047656DLL4 (navicixizumab) discontinued
592036Navicixizumab (DLL4, VEGFA)

Popular Products